NCT07353814

Brief Summary

This study will be conducted to compare the effectiveness of progressive inspiratory flow trigger sensitivity rising versus stepwise pressure support reduction as ventilator-based inspiratory muscle training methods on weaning and extubation success in mechanically ventilated patients with respiratory failure.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
10mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Jan 2026Mar 2027

First Submitted

Initial submission to the registry

December 1, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

11 months

First QC Date

December 1, 2025

Last Update Submit

January 17, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Spontaneous breathing trial (SBT)

    documenting the frequency (total number) of spontaneous breathing trials for each patient until successful extubation

    From initiation of the first SBT until successful extubation, up to 48 hours

  • Burn's Wean Assessment Score

    Calculate the percentage of the total score to indicate the extent of improvement and the probable readiness for weaning (in %). The 26-item checklist assigns 1 point for "yes" responses, with a total score up to 26. Scores below 17 (65%) suggest insufficient readiness for weaning, while scores ≥ 17 indicate probable readiness for weaning.

    baseline (Day 1, prior to intervention) and immediately before initiation of successful SBT

  • Duration of MV

    defined as the time from study randomization to successful unassisted breathing (in days)

    from randomization to successful unassisted breathing, up to 48 hours

  • weaning success rate

    absence of ventilatory support 48 hours after discontinuation of MV. Inability to tolerate or pass SBT or to be liberated from invasive ventilatory support indicates weaning failure (in %).

    Within 48 hours following extubation

  • Extubation success rate

    defined as the proportion of subjects who did not die and were not re-intubated 48-72 hours after the scheduled extubation. The inability to sustain spontaneous breathing after removal of the endotracheal tube, requiring either reintubation or the use of NIV within this specified period, indicates extubation failure (in %).

    Within 72 hours following extubation

Secondary Outcomes (8)

  • Blood Gas analysis

    baseline (Day 1, prior to intervention) and within 48 hours after liberation from mechanical ventilation

  • Negative Inspiratory Force

    Baseline (Day 1, prior to intervention) and immediately following completion of successful SBT

  • Respiratory Rate

    Baseline (Day 1, prior to intervention) and immediately following completion of successful SBT

  • Minute Ventilation

    Baseline (Day 1, prior to intervention) and immediately following completion of successful SBT

  • Static Lung-Thorax Compliance

    Baseline (Day 1, prior to intervention) and immediately following completion of successful SBT

  • +3 more secondary outcomes

Study Arms (3)

Conventional Chest Physiotherapy

PLACEBO COMPARATOR

twenty mechanically ventilated patients with acute respiratory failure, who will receive the routine plan of weaning and conventional chest physiotherapy from MV twice a day with a 4-6 hour gap between for 4-5 days a week till extubation.

Other: routine plan of weaning and Conventional Chest Physiotherapy

Trigger Sensitivity IMT

EXPERIMENTAL

twenty mechanically ventilated patients with acute respiratory failure, who will receive inspiratory muscle training by gradual inspiratory flow trigger sensitivity optimization in addition to the routine plan of weaning and conventional chest physiotherapy from MV, twice a day with a 4-6 hour gap between, for 4-5 days a week till extubation.

Other: adjustment of parameters on mechanical ventilation deviceOther: routine plan of weaning and Conventional Chest Physiotherapy

Stepwise Pressure Support Reduction IMT

EXPERIMENTAL

twenty mechanically ventilated patients with acute respiratory failure, who will receive inspiratory muscle training via stepwise pressure support reduction in addition to the routine plan of weaning and conventional chest physiotherapy from MV, twice a day with a 4-6 hour gap between, for 4-5 days a week till extubation.

Other: adjustment of parameters on mechanical ventilation deviceOther: routine plan of weaning and Conventional Chest Physiotherapy

Interventions

adjust the parameters of the mode of training on mechanical ventilation according the group of patients

Stepwise Pressure Support Reduction IMTTrigger Sensitivity IMT

Chest Physiotherapy including: ▪ Postural Drainage ▪ Manual techniques for airway clearance (percussion, vibration, shaking) Adding to range of passive to active movements of the limbs

Conventional Chest PhysiotherapyStepwise Pressure Support Reduction IMTTrigger Sensitivity IMT

Eligibility Criteria

Age40 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Acute respiratory failure patients in the ICU are receiving MV for 48 h or more in a controlled mode.
  • Their ages will range from 40 to 55 years old, and both sexes will be included.
  • Conscious and oriented patients with a Glasgow coma score ≥13 (≥9T).
  • Alertness score with a Richmond Agitation-Sedation Scale (RASS) will be from 0 to -1.
  • All patients in this study must be hemodynamically and medically stable.
  • Patients must be able to trigger spontaneous breaths on the ventilator but couldn't generate maximum inspiratory pressure more than -15 mbar.

You may not qualify if:

  • Persistent hemodynamic instability as life-threatening conditions or comorbidities interfere with and compromise weaning, like cardiac arrhythmia, pericardial effusion, congestive heart failure, or acute coronary syndrome.
  • Severe breathlessness when spontaneously breathing.
  • Any progressive neuromuscular disease, such as myopathy or neuropathy, that would interfere with responding to inspiratory muscle training due to inadequate training performance of the inspiratory muscle.
  • Spinal cord injury.
  • Skeletal pathology (scoliosis, flail chest, spinal instrumentation) that would seriously impair the movement of the chest wall and ribs.
  • Patients in a coma or under heavy sedation (RASS ≤ -2) and with respiratory muscle paralysis.
  • High peak airway pressure (barotrauma), high PEEP \>10, or active pneumothorax.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

kasr Al Ainy Hospital

Cairo, Giza Governorate, 11956, Egypt

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Mahmoud E Ragab, M.Sc.

    Kasr Al Ainy hospital, Cairo University

    PRINCIPAL INVESTIGATOR
  • Nesreen G' EL-NAHAS, PhD

    Cairo University

    STUDY CHAIR

Central Study Contacts

Mahmoud E Ragab, MSc

CONTACT

SHYMAA T Mohamed, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
only the investigator knows the applied training method, once randomization is happened and the patient enrolled in his specific group
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer Dr.

Study Record Dates

First Submitted

December 1, 2025

First Posted

January 20, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

data is available with the corresponding author on reasonable request

Locations